The question to ask yourself is how a company $15M in debt, one that added $3M more debt in 2018, is going to uplist. They can certainly do this, and executives in the company could make out like bandits. But shareholders won't. To accomplish this, they increase the AS to 6 billion (already done), dilute those shares to pay down their debt (the next two years for DRUS), do a reverse split of something absurd like 1:1000 concurrently with a $50M offering of new shares to meet the minimum market cap for uplisting. Bannon would still get his salary and feel good about NASDAQ status, but shareholder value gets wiped out this way. Don't take my word for it - read the SEC filings and look at how other OTCs uplist and what becomes of the original shareholders. There can be very short hyped up pops in the share price that benefit only those who bought at rock bottom, but otherwise shareholders don't benefit. All that said, anyone can make money on any stock on any given day, as DRUS proved a couple weeks ago. I'm not advising anything but a realistic view of the process of uplisting given the financial situation of DRUS.
News 
Market Data 
Discover 
